Clinical Trial Detail

NCT ID NCT01674270
Title Degarelix Neo-Adjuvant Radical Prostatectomy Trial
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

prostate cancer

Therapies

Bicalutamide

Degarelix

Age Groups: senior adult

No variant requirements are available.